Article
Characterization and comparison of transgenic Artemisia annua GYR and wild-type NON-GYR plants in an environmental release trial.
Genetics and molecular research : GMR - 26 Aug 2016
Liu H, Wu G G, Wang J B, Wu X, Bai L, Jiang W, Lv B B, Pan A H, Jia J W, Li P, Zhao K, Jiang L X, Tang X M
Abstract excerpt
The anti-malarial drug, artemisinin, is quite expensive as a result of its slow content in Artemisia annua. Recent investigations have suggested that genetic engineering of A. annua is a promising approach to improve the yield of artemisinin. In this study, the transgenic A. annua strain GYR, which has high artemisinin content, was evaluated in an environmental release trial. First, GYR plants were compared with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.